PExA AB (publ) (FRA:FA0)

Germany · Delayed Price · Currency is EUR

0.0192

-0.0004 (-2.04%)

Last updated: Oct 23, 2026, 3:25 PM CEST

Market Cap	3.45M +91.2%
Revenue (ttm)	122.25K +66.6%
Net Income	-350.63K
EPS	-0.00
Shares Out	n/a
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	n/a
Open	0.0190
Previous Close	0.0196
Day's Range	0.0190 - 0.0196
52-Week Range	0.0105 - 0.0542
Beta	n/a
Analysts	n/a
Price Target	n/a
Est. Earnings	Nov 6, 2026

About PExA AB

PExA AB (publ) develops and commercializes diagnostic products for various respiratory diseases. It offers products for asthma, tuberculosis, cystic fibrosis, lung cancer, and chronic obstructive pulmonary disease. The company’s research instrument helps lung researchers in the collection of microscopic particles and biomarkers for diseases in the small airways. It offers PExA 2.0, an instrument for the non-invasive collection of particles in exhaled air. The company also provides accessories, which include substrate surfaces and nozzles, as we...

Industry Laboratory Analytical Instruments

Founded 2004

Employees 3

Stock Exchange Frankfurt Stock Exchange

Ticker Symbol FA0